Article
How to Demonstrate the Glucose Specificity of a Non-Invasive CGM: A Case Study of the SKAMo-2 Clinical Trial and Neogly™
2026-08-18
Abstract excerpt
<h4>Background</h4> Every non-invasive continuous glucose monitoring (NI-CGM) technology introduced into the landscape faces the same skeptical question, from regulators, clinicians, and competing developers alike: is the candidate signal actually specific to glucose, or does an apparently reasonable accuracy figure simply reflect a model fitting to motion, temperature, calibration offset, or trial-duration artif...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8ea7e1ea-65df-5933-8b51-04266f689fd4
- DOI
- 10.64898/2026.08.17.26360581
